HIP
PACB icon

HUB Investment Partners’s Pacific Biosciences PACB Stock Holding History

HUB Investment Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
75,000
+8,000
+12% +$11.6K ﹤0.01% 1261
2026
Q1 		$88.4K Buy
67,000
+5,100
+8% +$9.12K ﹤0.01% 1074
2025
Q4 		$116K Hold
61,900
– – ﹤0.01% 891
2025
Q3 		$79.2K Hold
61,900
– – ﹤0.01% 769
2025
Q2 		$76.8K Buy
+61,900
New +$71.5K ﹤0.01% 692

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HUB Investment Partners's PACB Position: Q2 2026 in Review

HUB Investment Partners increased its Pacific Biosciences (PACB) stake by 12% in Q2 2026, buying an estimated $11.6K and bringing the position to 75,000 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

HUB Investment Partners first reported a position in PACB in Q2 2025 and has held it in 5 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • HUB Investment Partners held 75,000 shares of Pacific Biosciences worth $126K as of Q2 2026.
  • HUB Investment Partners bought 8,000 Pacific Biosciences shares in Q2 2026, an estimated $11.6K.
  • Pacific Biosciences made up ﹤0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1261 holding.
  • HUB Investment Partners first reported a position in Pacific Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.